Mutations in or near the transmembrane domain alter PMEL amyloid formation from functional to pathogenic
about
PMEL Amyloid Fibril Formation: The Bright Steps of PigmentationInactivation of Pmel alters melanosome shape but has only a subtle effect on visible pigmentationMelanocytes and their diseasesEquine multiple congenital ocular anomalies and silver coat colour result from the pleiotropic effects of mutant PMEL.The Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation.Critical residues in the PMEL/Pmel17 N-terminus direct the hierarchical assembly of melanosomal fibrils.PMEL: a pigment cell-specific model for functional amyloid formationThe amyloid state of proteins in human diseases.Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures.Study of Exosomes Shed New Light on Physiology of Amyloidogenesis.Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.Melanosome-autonomous regulation of size and number: the OA1 receptor sustains PMEL expression.Amyloids, melanins and oxidative stress in melanomagenesis.Screening for transmembrane association in divisome proteins using TOXGREEN, a high-throughput variant of the TOXCAT assayReduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.Why are Functional Amyloids Non-Toxic in Humans?Energetics Underlying Twist Polymorphisms in Amyloid Fibrils.Molecular Genetics of Pigment Dispersion Syndrome and Pigmentary Glaucoma: New Insights into Mechanisms.Length variations within the retrotransposon of canine : correlating genotype with phenotype
P2860
Q28076932-F0037E36-47C7-44A9-9D20-7BB8EDEFF00CQ28585331-FE43E7F6-CAD7-43CB-9390-94822827D133Q28658506-DACA4B1E-79E7-4E4E-9658-1F0C12C5FA54Q31140523-4A34ECF4-ABFD-42EA-94A3-E62073F715FDQ36574029-51B953B3-DBCA-45F3-9D9A-07D11E7BE7B0Q36717393-E64C2B7F-A4DE-474E-A8FF-E937F4122EBFQ36788313-91AF1161-1678-47A0-8EF0-E6E63300BE27Q37994283-4308BD18-6CC7-4977-8DFA-C60BA9E01509Q38639510-9264CFF0-EB99-4BE1-90B5-67B73D3991A0Q38777380-7A365942-6AB5-475A-85B6-722777D6580EQ38798375-63F168D3-226B-4539-989A-1CB4469C4E0AQ39013582-A431067A-E06B-4222-A10E-D7804120D747Q42089651-4BD31794-C593-4CAB-8CE3-D576D63812A8Q42633335-945FA112-6252-4446-9ADF-ED943B710040Q44607866-FFCB014F-0876-469F-9AB3-ED2B586BBC49Q46302841-8386A2E7-7465-4AC5-8462-E9418C89BCCFQ47279865-94BE88EF-77A7-4E63-80A4-281F93D48700Q54943357-960ED8C0-79D2-42D8-928C-3CAF36C8D25FQ58801365-5B541149-C4A8-4668-BE31-CD1C0F4B1955
P2860
Mutations in or near the transmembrane domain alter PMEL amyloid formation from functional to pathogenic
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mutations in or near the trans ...... from functional to pathogenic
@ast
Mutations in or near the trans ...... from functional to pathogenic
@en
Mutations in or near the trans ...... from functional to pathogenic
@nl
type
label
Mutations in or near the trans ...... from functional to pathogenic
@ast
Mutations in or near the trans ...... from functional to pathogenic
@en
Mutations in or near the trans ...... from functional to pathogenic
@nl
prefLabel
Mutations in or near the trans ...... from functional to pathogenic
@ast
Mutations in or near the trans ...... from functional to pathogenic
@en
Mutations in or near the trans ...... from functional to pathogenic
@nl
P2093
P2860
P50
P1433
P1476
Mutations in or near the trans ...... from functional to pathogenic
@en
P2093
Brenda Watt
Graça Raposo
Susanne Kerje
P2860
P304
P356
10.1371/JOURNAL.PGEN.1002286
P577
2011-09-15T00:00:00Z